Health Affairs, 25, no. 5 (2006): 1240-1248 doi: 10.1377/hlthaff.25.5.1240 © 2006 by Project HOPE	New Online   Pay Cuts For Medicare Docs   Access To Care Woes   Public Coverage More Efficient   Empowering Consumers

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Bowman, J. Articles by Harrison, C. Search for Related Content PubMed PubMed Citation Articles by Bowman, J. Articles by Harrison, C. Related Collections Insurance Market Access To Care Business Of Health Consumer Issues Evidence-Based Medicine Insurance Coverage Managed Care - Medicare Medicare Pharmaceuticals Research And Technology Health Spending

Coverage

Access To Cancer Drugs In Medicare Part D: Formulary Placement And Beneficiary Cost Sharing In 2006

The Medicare Part D benefit expands the universe of cancer drugs and biologics that Medicare may cover. Individual Part D plans have discretion to determine their formularies and cost sharing for drugs within federal guidelines. This paper analyzes differences in coverage and cost sharing for cancer drugs among these plans. We find that many cancer drugs, including brand-name products, are covered by almost all plans, although prior authorization might limit access to some. In addition, many plans charge a relatively low copayment for most cancer drugs. These findings suggest that Part D could greatly expand beneficiaries’ access to cancer treatments.

                      What's this?

This article has been cited by other articles:

				P. Neuman, M. K. Strollo, S. Guterman, W. H. Rogers, A. Li, A. M. C. Rodday, and D. G. Safran Medicare Prescription Drug Benefit Progress Report: Findings From A 2006 National Survey Of Seniors Health Aff., September 1, 2007; 26(5): w630 - w643. [Abstract] [Full Text] [PDF]